Detalhe da pesquisa
1.
Whole-genome sequencing reveals complex genomic features underlying anti-CD19 CAR T-cell treatment failures in lymphoma.
Blood
; 140(5): 491-503, 2022 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35476848
2.
Functional drivers of resistance to anti-CD19 CAR-T cell therapy in diffuse large B cell lymphoma.
Leuk Lymphoma
; 64(14): 2217-2224, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37933565
3.
Proteomics reveal cap-dependent translation inhibitors remodel the translation machinery and translatome.
Cell Rep
; 37(2): 109806, 2021 10 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34644561
4.
Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.
Nat Med
; 24(5): 679-690, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29713087
5.
Author Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.
Nat Med
; 24(8): 1290-1291, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29955182
6.
Publisher Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.
Nat Med
; 24(8): 1292, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29955181